These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22746405)

  • 1. Postantifungal effect of the combination of caspofungin with voriconazole and amphotericin B against clinical Candida krusei isolates.
    Oz Y; Kiremitci A; Dag I; Metintas S; Kiraz N
    Med Mycol; 2013 Jan; 51(1):60-5. PubMed ID: 22746405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Broth microdilution and time-kill testing of Caspofungin, voriconazole, amphotericin B and their combinations against clinical isolates of Candida krusei.
    Oz Y; Dag I; Kiraz N
    Mycopathologia; 2012 Jan; 173(1):27-34. PubMed ID: 21842180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro pharmacodynamic characteristics of amphotericin B, caspofungin, fluconazole, and voriconazole against bloodstream isolates of infrequent Candida species from patients with hematologic malignancies.
    Di Bonaventura G; Spedicato I; Picciani C; D'Antonio D; Piccolomini R
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4453-6. PubMed ID: 15504881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro combined activity of amphotericin B, caspofungin and voriconazole against clinical isolates of Trichosporon asahii.
    Li H; Lu Q; Wan Z; Zhang J
    Int J Antimicrob Agents; 2010 Jun; 35(6):550-2. PubMed ID: 20202797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Short communication: In vitro activity of amphotericin B with fluconazole or voriconazole combinations against Candida albicans isolates].
    Oz Y; Akşit F; Kiraz N; Kiremitçi A
    Mikrobiyol Bul; 2008 Jan; 42(1):149-55. PubMed ID: 18444574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evaluation of in vitro pharmacodynamic properties of amphotericin B, voriconazole and caspofungin against A. fumigatus isolates by the conventional and colorimetric time-kill assays.
    Kiraz N; Oz Y; Dag I
    Med Mycol; 2011 Aug; 49(6):594-601. PubMed ID: 21299374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro synergy of caspofungin with licensed and novel antifungal drugs against clinical isolates of Fusarium spp.
    Shalit I; Shadkchan Y; Mircus G; Osherov N
    Med Mycol; 2009; 47(5):457-62. PubMed ID: 18720217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activities of voriconazole as a triazole derivative and caspofungin as an echinocandin were compared with those of some antifungal agents against Candida species isolated from clinical specimens.
    Ozçelik B; Kaynak F; Cesur S; Sipahi B; Sultan N
    Jpn J Infect Dis; 2007 Sep; 60(5):302-4. PubMed ID: 17881873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multilaboratory testing of antifungal combinations against a quality control isolate of Candida krusei.
    Chaturvedi V; Ramani R; Ghannoum MA; Killian SB; Holliday N; Knapp C; Ostrosky-Zeichner L; Messer SA; Pfaller MA; Iqbal NJ; Arthington-Skaggs BA; Vazquez JA; Sein T; Rex JH; Walsh TJ
    Antimicrob Agents Chemother; 2008 Apr; 52(4):1500-2. PubMed ID: 18227180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro antifungal combination effects of micafungin with fluconazole, voriconazole, amphotericin B, and flucytosine against clinical isolates of Candida species.
    Nishi I; Sunada A; Toyokawa M; Asari S; Iwatani Y
    J Infect Chemother; 2009 Feb; 15(1):1-5. PubMed ID: 19280292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caspofungin in combination with amphotericin B against Candida parapsilosis.
    Barchiesi F; Spreghini E; Tomassetti S; Giannini D; Scalise G
    Antimicrob Agents Chemother; 2007 Mar; 51(3):941-5. PubMed ID: 17158939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multilaboratory testing of two-drug combinations of antifungals against Candida albicans, Candida glabrata, and Candida parapsilosis.
    Chaturvedi V; Ramani R; Andes D; Diekema DJ; Pfaller MA; Ghannoum MA; Knapp C; Lockhart SR; Ostrosky-Zeichner L; Walsh TJ; Marchillo K; Messer S; Welshenbaugh AR; Bastulli C; Iqbal N; Paetznick VL; Rodriguez J; Sein T
    Antimicrob Agents Chemother; 2011 Apr; 55(4):1543-8. PubMed ID: 21282457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of antifungal combinations against Candida albicans biofilms.
    Tobudic S; Kratzer C; Lassnigg A; Graninger W; Presterl E
    J Antimicrob Chemother; 2010 Feb; 65(2):271-4. PubMed ID: 19996142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifungal susceptibility of ocular fungal pathogens recovered from around the world against itraconazole, voriconazole, amphotericin B, and caspofungin.
    Ozdemir HG; Oz Y; Ilkit M; Kiraz N
    Med Mycol; 2012 Feb; 50(2):130-5. PubMed ID: 21599550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the fungicidal activities of caspofungin and amphotericin B against Candida glabrata.
    Barchiesi F; Spreghini E; Tomassetti S; Arzeni D; Giannini D; Scalise G
    Antimicrob Agents Chemother; 2005 Dec; 49(12):4989-92. PubMed ID: 16304162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal activity against Candida albicans of nikkomycin Z in combination with caspofungin, voriconazole or amphotericin B.
    Sandovsky-Losica H; Shwartzman R; Lahat Y; Segal E
    J Antimicrob Chemother; 2008 Sep; 62(3):635-7. PubMed ID: 18490373
    [No Abstract]   [Full Text] [Related]  

  • 17. Minimum inhibitory concentrations of amphotericin B, azoles and caspofungin against Candida species are reduced by farnesol.
    Cordeiro RA; Teixeira CE; Brilhante RS; Castelo-Branco DS; Paiva MA; Giffoni Leite JJ; Lima DT; Monteiro AJ; Sidrim JJ; Rocha MF
    Med Mycol; 2013 Jan; 51(1):53-9. PubMed ID: 22712455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of caspofungin and voriconazole against uncommon Candida spp.
    Enache-Angoulvant A; Girard A; Poirot JL; Hennequin C
    Int J Antimicrob Agents; 2009 Jun; 33(6):595-6. PubMed ID: 19162450
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative pharmacodynamic interaction analysis of triple combinations of caspofungin and voriconazole or ravuconazole with subinhibitory concentrations of amphotericin B against Aspergillus spp.
    Demchok JP; Meletiadis J; Roilides E; Walsh TJ
    Mycoses; 2010 May; 53(3):239-45. PubMed ID: 19389068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activities of voriconazole in combination with three other antifungal agents against Candida glabrata.
    Barchiesi F; Spreghini E; Maracci M; Fothergill AW; Baldassarri I; Rinaldi MG; Scalise G
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3317-22. PubMed ID: 15328091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.